Great West Life Assurance CO Exact Sciences Corp Transaction History

Great West Life Assurance CO

  • $58 Billion
  • Q4 2024

A detailed history of Great West Life Assurance CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Great West Life Assurance CO holds 65,283 shares of EXAS stock, worth $3.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
65,283
Previous 65,203 0.12%
Holding current value
$3.22 Million
Previous $4.45 Million 17.55%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$49.33 - $71.97 $3,946 - $5,757
80 Added 0.12%
65,283 $3.67 Million
Q3 2024

Nov 13, 2024
BUY
$42.43 - $70.83 $327,347 - $546,453
7,715 Added 13.42%
65,203 $4.45 Million
Q2 2024

Aug 12, 2024
SELL
$41.33 - $74.26 $6.19 Million - $11.1 Million
-149,876 Reduced 72.28%
57,488 $2.43 Million
Q1 2024

May 13, 2024
BUY
$56.27 - $73.77 $582,732 - $763,962
10,356 Added 5.26%
207,364 $14.4 Million
Q4 2023

Feb 13, 2024
BUY
$59.06 - $75.72 $8.43 Million - $10.8 Million
142,809 Added 263.49%
197,008 $14.5 Million
Q3 2023

Nov 14, 2023
SELL
$65.94 - $99.04 $161,618 - $242,747
-2,451 Reduced 4.33%
54,199 $3.69 Million
Q2 2023

Aug 10, 2023
SELL
$62.68 - $95.05 $557,538 - $845,469
-8,895 Reduced 13.57%
56,650 $5.35 Million
Q1 2023

May 12, 2023
SELL
$47.19 - $70.77 $9.23 Million - $13.8 Million
-195,556 Reduced 74.9%
65,545 $4.45 Million
Q4 2022

Feb 10, 2023
SELL
$30.35 - $53.15 $1.25 Million - $2.18 Million
-41,044 Reduced 13.58%
261,101 $13 Million
Q3 2022

Nov 01, 2022
BUY
$31.97 - $49.37 $9.66 Million - $14.9 Million
302,145 New
302,145 $9.88 Million
Q2 2022

Aug 09, 2022
BUY
$35.61 - $76.23 $7.05 Million - $15.1 Million
198,107 Added 158.13%
323,388 $12.7 Million
Q1 2022

May 12, 2022
SELL
$57.56 - $82.54 $566,966 - $813,019
-9,850 Reduced 7.29%
125,281 $9.27 Million
Q4 2021

Feb 14, 2022
SELL
$72.5 - $100.68 $77,720 - $107,928
-1,072 Reduced 0.79%
135,131 $10.5 Million
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $947,068 - $1.3 Million
10,495 Added 8.35%
136,203 $13.1 Million
Q2 2021

Aug 11, 2021
BUY
$93.66 - $139.27 $2.17 Million - $3.23 Million
23,220 Added 22.66%
125,708 $15.6 Million
Q1 2021

May 17, 2021
BUY
$116.57 - $155.01 $2.26 Million - $3 Million
19,352 Added 23.28%
102,488 $13.4 Million
Q4 2020

Feb 16, 2021
BUY
$99.61 - $142.12 $911,431 - $1.3 Million
9,150 Added 12.37%
83,136 $11 Million
Q3 2020

Nov 17, 2020
BUY
$72.92 - $102.01 $5.38 Million - $7.53 Million
73,835 Added 48897.35%
73,986 $7.54 Million
Q3 2020

Nov 13, 2020
SELL
$72.92 - $102.01 $4.54 Million - $6.36 Million
-62,299 Reduced 99.76%
151 $15,000
Q2 2020

Aug 17, 2020
BUY
$55.75 - $92.75 $152,922 - $254,413
2,743 Added 4.59%
62,450 $5.4 Million
Q1 2020

May 14, 2020
BUY
$37.9 - $104.44 $16,145 - $44,491
426 Added 0.72%
59,707 $3.48 Million
Q4 2019

Feb 11, 2020
BUY
$77.66 - $99.74 $4.6 Million - $5.91 Million
59,281 New
59,281 $5.48 Million
Q3 2019

Oct 25, 2019
SELL
$90.37 - $122.49 $2.74 Million - $3.71 Million
-30,314 Closed
0 $0
Q2 2019

Jul 31, 2019
BUY
$89.51 - $118.04 $1.21 Million - $1.59 Million
13,489 Added 80.17%
30,314 $0
Q1 2019

May 08, 2019
BUY
$61.98 - $96.5 $119,063 - $185,376
1,921 Added 12.89%
16,825 $1.45 Million
Q4 2018

Feb 12, 2019
BUY
$56.04 - $82.66 $99,695 - $147,052
1,779 Added 13.55%
14,904 $908,000
Q1 2018

May 10, 2018
SELL
$39.82 - $57.53 $90,112 - $130,190
-2,263 Reduced 14.71%
13,125 $530,000
Q4 2017

Feb 09, 2018
BUY
$46.49 - $60.51 $96,885 - $126,102
2,084 Added 15.66%
15,388 $807,000
Q3 2017

Nov 09, 2017
BUY
$37.05 - $47.12 $492,913 - $626,884
13,304
13,304 $616,000

Others Institutions Holding EXAS

# of Institutions
683
Shares Held
163M
Call Options Held
3.42M
Put Options Held
2.34M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email